Schedule III Cannabis: FDA’s New Frontier
Article by: Raza Lawrence and Ivy Perez-Bader Federal cannabis rescheduling has been widely discussed as a tax, banking, and criminal law inflection point. Far less attention has been paid to what may ultimately be its most consequential effect: a re-centering of federal food and drug law in an industry that has largely developed outside of it.…






